AppLovin Corporation

(NASDAQ Global Select)
Back to all articles
Bullish +75

AppLovin (APP) Price Target Raised by Piper Sandler to $665

AI-generated analysis

πŸ“ˆ Piper Sandler raised its price target on AppLovin (APP) from $650 to $665 while maintaining an Overweight rating.

πŸ“… This update was released on May 7, marking the latest analyst action on the aggressive growth stock.

πŸ“Š The firm highlighted AppLovin's biggest revenue beat in approximately four quarters as a key positive driver.

πŸ€– Analyst James Callahan noted continued strength in mediation supporting the company's MAX and ROAS bidding advantages.

πŸ“‰ Despite investor concerns regarding competition, Piper Sandler sees strong fundamentals persisting without clear macroeconomic pressure.

πŸ’° AppLovin is valued at roughly 22 times its estimated 2027 GAAP earnings per share, which analysts consider reasonable.

πŸ›‘οΈ The company holds a solid financial position while offering end-to-end AI solutions for business audience growth and monetization.

⚠️ Piper Sandler cautioned that certain other AI stocks may offer greater upside potential with less downside risk compared to APP.

πŸ“ˆ Readers are directed to a free report on short-term AI stocks potentially benefiting from Trump-era tariffs and onshoring trends.

πŸ”— Additional coverage is available on 10 mid-cap stocks performing well and US stocks under $5 to buy.

ℹ️ The article includes a standard disclosure stating there were no conflicts of interest or holdings by the publishing team.

πŸ€– AppLovin continues to be recognized by Wall Street analysts as one of the top aggressive growth stocks to consider.

Bullish Signals
  • Piper Sandler raised its price target on AppLovin (APP) from $650 to $665 while maintaining an Overweight rating.
  • AppLovin achieved its biggest percentage revenue beat in approximately four quarters, highlighting strong fundamental performance.
  • Analysts believe AppLovin has a mediation advantage and benefits from the MAX and ROAS bidding platforms despite competitive concerns.
  • The company's guidance remains cautious with no clear signs of macroeconomic pressure impacting operations.
  • AppLovin maintains a solid financial position with a reasonable valuation at about 22 times estimated 2027 GAAP earnings per share.
Risk Factors
  • Analyst James Callahan notes that the company's guidance appears cautious, signaling potential conservatism in future expectations.
  • Investor worries about competition persist despite Piper Sandler's bullish stance, indicating an external risk factor for the stock.
  • The analyst explicitly states that while APP is a viable investment, other AI stocks offer greater upside potential and carry less downside risk, positioning AppLovin as a relatively riskier alternative in the sector.
Full Analysis
Piper Sandler analyst James Callahan raised the price target for AppLovin (APP) from $650 to $665 while maintaining an Overweight rating. This adjustment follows the company's biggest quarterly revenue beat in roughly four quarters, indicating continued strong fundamentals despite broader investor concerns regarding competition. The research firm highlighted validation of the company's mediation capabilities and its competitive advantage in MAX and return on ad spend (ROAS) bidding technology. Analysts also noted that AppLovin’s forward guidance remains cautious with no immediate signs of macroeconomic pressure impacting performance. The analysis suggests AppLovin maintains a reasonable valuation relative to growth prospects, trading at approximately 22 times its estimated 2027 GAAP earnings per share. The company is described as an American technology provider offering end-to-end software and artificial intelligence solutions designed to help businesses of various sizes reach, monetize, and grow their user audiences. Although Piper Sandler acknowledges APP's investment potential, the report notes that other AI stocks may currently offer greater upside with less downside risk. The article concludes without specific disclosure regarding conflicts of interest or holds by the research firm’s analysts.